US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neon Therapeutics Inc.

3.07

0.0000

Volume:- -

Turnover:- -

Market Cap:88.93M

PE:-1.14

High:3.07

Open:3.07

Low:3.07

Close:3.07

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Neon Therapeutics Inc.

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.neontherapeutics.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Neon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It is developing NEO-PV-01, a neoantigen vaccine that is in Phase Ib clinical trial for the treatment of advanced or metastatic non-small cell lung cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; and NEO-SV-01, a neoantigen vaccine for the treatment of hormone-receptor-positive breast cancer, as well as NEO-STC-01, a neoantigen adoptive T cell therapy for the treatment of cancers driven or mediated by RAS mutations. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NTGN/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTGN\",,,,,undefined,":{"symbol":"NTGN","market":"US","secType":"STK","nameCN":"Neon Therapeutics Inc.","latestPrice":3.07,"timestamp":1588708800000,"preClose":3.07,"halted":3,"volume":0,"delay":0,"floatShares":15196186,"shares":28966658,"eps":-2.681502,"marketStatus":"Halted","change":0,"latestTime":"05-21 10:24:52 EDT","open":3.07,"high":3.07,"low":3.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.681502,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1747857600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1530072000000,"exchange":"NASDAQ","adjPreClose":3.07,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTGN\",,,,,undefined,":{"symbol":"NTGN","floatShares":15196186,"roa":"-70.63%","roe":"-156.16%","lyrEps":-2.861539,"shares":28966658,"dividePrice":0,"high":3.07,"amplitude":0,"preClose":3.07,"low":3.07,"week52Low":0.88,"pbRate":"6.16","week52High":6.15,"institutionHeld":0,"latestPrice":3.07,"eps":-2.681502,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.681502,"open":3.07,"prevYearClose":1.18},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.neontherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0102},{"period":"1month","weight":0.1262},{"period":"3month","weight":-0.0328},{"period":"6month","weight":-0.0014},{"period":"1year","weight":0.1185},{"period":"ytd","weight":0.0116}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Neon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It is developing NEO-PV-01, a neoantigen vaccine that is in Phase Ib clinical trial for the treatment of advanced or metastatic non-small cell lung cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; and NEO-SV-01, a neoantigen vaccine for the treatment of hormone-receptor-positive breast cancer, as well as NEO-STC-01, a neoantigen adoptive T cell therapy for the treatment of cancers driven or mediated by RAS mutations. The company was founded in 2013 and is headquartered in Cambridge, Massachusetts.","exchange":"NASDAQ","name":"Neon Therapeutics Inc.","nameEN":"Neon Therapeutics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NTGN\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-01","symbol":"NTGN","fiscalQuarterEnding":"2020/03","expectedEps":-0.27,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1588305600000,"reportTimeType":"pre","actualEps":-0.58},{"market":"US","date":"2019-11-12","symbol":"NTGN","fiscalQuarterEnding":"2019/09","expectedEps":-0.61,"name":null,"time":"","type":"earning","dateTimestamp":1573534800000,"reportTimeType":"","actualEps":-0.68},{"market":"US","date":"2019-08-06","symbol":"NTGN","fiscalQuarterEnding":"2019/06","expectedEps":-0.81,"name":null,"time":"","type":"earning","dateTimestamp":1565064000000,"reportTimeType":"","actualEps":-0.79},{"market":"US","date":"2019-05-13","symbol":"NTGN","fiscalQuarterEnding":"2019/03","expectedEps":-0.71,"name":null,"time":"","type":"earning","dateTimestamp":1557720000000,"reportTimeType":"","actualEps":-0.76},{"market":"US","date":"2019-03-11","symbol":"NTGN","fiscalQuarterEnding":"2018/12","expectedEps":-0.73,"name":null,"time":"","type":"earning","dateTimestamp":1552276800000,"reportTimeType":"","actualEps":-0.84}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NTGN\",market:\"US\",delay:false,,,undefined,":{}}}